Sareum Holdings (LSE:SAR) EBITDA Margin %: 0.00% (As of Dec. 2025)


LSE:SAR Sareum Holdings PLC LSE:SAR
32 GF Score
Price £0.21
! 3 Warning Signs
View Full Analysis

What is Sareum Holdings EBITDA Margin %?

Sareum Holdings LSE:SAR -8.70% 32 EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus rates LSE:SAR with a GF Score™ of 32/100. The stock has 3 warning signs investors should review. Among 944 Biotechnology companies, Sareum Holdings ranks worse than 105932.1% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Sareum Holdings's EBITDA for the six months ended in Dec. 2025 was £-1.82 Mil. Sareum Holdings's Revenue for the six months ended in Dec. 2025 was £0.00 Mil. Therefore, Sareum Holdings's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.

Sareum Holdings  (LSE:SAR) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Sareum Holdings EBITDA Margin % Related Terms

Sareum Holdings EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Sareum Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sareum Holdings EBITDA Margin % Chart

Sareum Holdings Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sareum Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

LSE:SAR vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, Sareum Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sareum Holdings EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sareum Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Sareum Holdings's EBITDA Margin % falls into.


LSE:SAR
32GF Score
Sareum Holdings PLC LSE:SAR
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sareum Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Sareum Holdings's EBITDA Margin % for the fiscal year that ended in Jun. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-3.382/0
= %

Sareum Holdings's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-1.82/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Sareum Holdings (LSE:SAR) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sareum Holdings and its competitors. According to the industry distribution chart, Sareum Holdings ranks #999999 out of 944 companies in the Biotechnology industry.
Is Sareum Holdings' EBITDA Margin % too high?
Sareum Holdings' current EBITDA Margin % is 0.00%. Based on the distribution chart, Sareum Holdings ranks #999999 out of 944 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Sareum Holdings has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Sareum Holdings' EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sareum Holdings ranks #999999 out of 944 companies for EBITDA Margin %. This places Sareum Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sareum Holdings and its competitors. Sareum Holdings's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sareum Holdings stock overvalued right now?
Sareum Holdings (LSE:SAR) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Sareum Holdings' overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Sareum Holdings (LSE:SAR), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sareum Holdings Business Description

Address Langford Arch, London Road, Unit 2a, Pampisford, Cambridge, Cambridgeshire, GBR, CB22 3FX
Sareum Holdings PLC is engaged in drug discovery and development. The company is focused on cancer and autoimmune diseases and licensing them to pharmaceutical and biotechnology companies. The company's drug pipeline includes SDC-1801 for autoimmune diseases, SDC-1802 for cancers, SRA737 targeting solid tumors among others.
32GF Score

Get the complete analysis for LSE:SAR

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.21
Price